Evidence map›Paper›PMID 40363775›Full record

ArticleMolecules (Basel, Switzerland)2025

Synthesis and Characterisation of Multivariate Metal-Organic Frameworks for Controlled Doxorubicin Absorption and Release.

Ahmed Ahmed, Andrey Bezrukov, Debobroto Sensharma, Ciaran O'Malley, Michael J Zaworotko, Davide Tiana, Constantina Papatriantafyllopoulou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmed AhmedSSPC Research Ireland Centre for Pharmaceuticals, Ireland.ORCID 0000-0002-9197-7786
Andrey BezrukovDepartment of Chemical Sciences, Bernal Institute, University of Limerick, V94 T9PX Limerick, Ireland.
Debobroto SensharmaSSPC Research Ireland Centre for Pharmaceuticals, Ireland.
Ciaran O'MalleySchool of Biological and Chemical Sciences, College of Science and Engineering, University of Galway, H91 TK33 Galway, Ireland.
Michael J ZaworotkoSSPC Research Ireland Centre for Pharmaceuticals, Ireland.
Davide TianaSSPC Research Ireland Centre for Pharmaceuticals, Ireland.ORCID 0000-0002-3627-1561
Constantina PapatriantafyllopoulouSSPC Research Ireland Centre for Pharmaceuticals, Ireland.

Funding

Taighde Éireann - Research Ireland 12/RC/2275_P2
6 · The paper itself

Abstract

The development of drug carriers with efficient absorption and controlled delivery properties is crucial for advancing medical treatments. Metal-organic frameworks (MOFs) with tunable porosity and a large surface area represent a promising class of materials for this application. Among them,

Indexed as

DoxorubicinDrug CarriersMetal-Organic FrameworksCrystallography, X-RayDelayed-Action PreparationsDrug LiberationModels, MolecularX-Ray DiffractionDelayed-Action PreparationsDoxorubicinDrug CarriersMetal-Organic Frameworksdoxorubicindrug deliveryfunctionalisationmetal–organic frameworksmultivariate MOFs

Identifiers

PMID40363775
PMCPMC12073425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.